Researchers from MIT and Massachusetts General Hospital have developed an automated model that assesses dense breast tissue in mammograms—which is an independent risk factor for breast cancer—as reliably as expert radiologists.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
